Evidence map›Paper›PMID 42228723›Full record

ArticlePloS one2026

Prerequisites and challenges of the role played by death Doula for supporting patients with cancer in end-of-life (EOL) stages: Qualitative study.

Imane Bagheri, Atena Dadgari, Naiire Salmani

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Imane BagheriResearch Center for Nursing and Midwifery Care, Comprehensive Research Institute for Maternal and Child Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Atena DadgariResearch Center for Nursing and Midwifery Care, Comprehensive Research Institute for Maternal and Child Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Naiire SalmaniMeybod School of Medical Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.ORCID https://orcid.org/0000-0002-4723-0984

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

End-of-life (EOL) doulas support dying people and their families. They are a response to the expectations of healthcare professionals (including palliative care providers) in end-of-life situations.The present study aimed to explore the perspective of palliative care team members about the prerequisites and challenges of the role played by death doulas to support patients with cancer in EOL stages. This qualitative study was conducted in 2023-2024 through in-depth semi-structured interviews with 14 healthcare staff. Participants were selected using purposive sampling considering maximum diversity and the study's inclusion criteria. Conventional content analysis using Lundman and Graneheim's approach were applied for data analysis. Data analysis revealed two main themes: the prerequisite for establishing the doula role (categories:drivers for shaping the doula role, recruitment and training of doulas, infrastructural preparation) and challenges ahead (categories:patient/family unawareness and lack of formal recognition). Based on the findings, policymakers and planners can develop operational programs to establish the role of death doulas and, by taking anticipated potential challenges into account, formulate preventive strategies. Furthermore, in light of the identified educational gaps, comprehensive educational content can be designed to adequately prepare death doulas for their roles.

Indexed as

DoulasNeoplasmsPalliative CareTerminal CareAdultFemaleHealth PersonnelHumansMaleMiddle AgedQualitative Research

Identifiers

PMID42228723
PMCPMC13229338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.